Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07090083 · ClinicalTrials.gov registry record

Pediatric Metabolic Dysfunction-associated Steatotic Liver Disease and Food Insecurity

A clinical trial of Food Insecurity and MASLD - Metabolic Dysfunction-Associated Steatotic Liver Disease, sponsored by University of California, San Francisco.

Recruiting
Registry status
160
Enrollment target
1
Study location

NCT07090083: Recruiting study of Food Insecurity and MASLD - Metabolic Dysfunction-Associated Steatotic Liver Disease, sponsored by University of California, San Francisco.

NCT07090083 is a study of Food Insecurity and MASLD - Metabolic Dysfunction-Associated Steatotic Liver Disease that is actively recruiting participants, run by University of California, San Francisco. The registered enrollment target is 160 participants, below the 7,735-participant average among 37 other Food Insecurity trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07090083, a study of Food Insecurity and MASLD - Metabolic Dysfunction-Associated Steatotic Liver Disease, is actively recruiting participants, sponsored by University of California, San Francisco.

RECRUITING
Registry status
160 participants
Enrollment target
1
Study location

Study Summary

This proposal addresses a critical gap in our understanding of the impact of household food insecurity (FI) on pediatric metabolic dysfunction-associated steatotic liver disease (MASLD) severity. There is evidence that children in families that do not have the ability to provide consistently healthy and high-quality foods, such as fruits and vegetables, have worse diet quality that children in households that are food secure. Additionally, evidence from adult studies link household FI to MASLD and liver fibrosis, and prior research of the PI has shown that exposure to household FI in early childhood was associated with a nearly 4 times increased odds of pediatric MASLD in middle childhood. Possible mechanisms linking household FI to pediatric MASLD include lower intake of fruits and vegetables, higher intake of caloric dense nutrient poor foods (e.g., sugar sweetened beverages), and less diversity of foods. Given consensus recommendations for the management of MASLD focus on lifestyle modification, i.e., diet and exercise to achieve weight loss, this proposal seeks to explore the association of household FI and pediatric MASLD disease severity and whether those effects are mediated by dietary intake. Study participants include children/adolescents with MASLD who are receiving care at UCSF's liver clinic and Weight Management for Teen and Child Health (WATCH) Clinic, a pediatric subspecialty clinic.

Primary Outcome

Alanine aminotransferase (ALT)

Study Locations (1)

California

  • University of California, San Francisco - San Francisco

Trial Details

FieldValue
Enrollment Target 160 participants
Start Date 2025-07-30
Est. Completion 2026-12-30

What NCT07090083 shows while recruiting

NCT07090083 is an observational study that tracks outcomes without assigning an intervention. The registered 160 participants enrollment target is mid-sized for trials with a published cap, below the 7,735-participant average among 37 other Food Insecurity trials with a reported enrollment target (98% lower).

The record links to 2 conditions, with Food Insecurity appearing as the primary indexed condition, and to 0 interventions.

NCT07090083 reports a single indexed study location in California.

Frequently Asked Questions

What is clinical trial NCT07090083 about?

NCT07090083 is a clinical study titled "Pediatric Metabolic Dysfunction-associated Steatotic Liver Disease and Food Insecurity". This proposal addresses a critical gap in our understanding of the impact of household food insecurity (FI) on pediatric metabolic dysfunction-associated steatotic liver disease (MASLD) severity. There is evidence that children in families that do not have the ability to provide consistently healthy...

What is the current status of trial NCT07090083?

This trial is currently recruiting. The enrollment target is 160 participants. The study started on 2025-07-30. Estimated completion is 2026-12-30.

What conditions does trial NCT07090083 study?

This clinical trial studies the following conditions: Food Insecurity, MASLD - Metabolic Dysfunction-Associated Steatotic Liver Disease.

Who is sponsoring clinical trial NCT07090083?

This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07090083 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Food Insecurity

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT07090083's enrollment target sits among peer trials

160 22nd of 37 higher than 15 of 37 other Food Insecurity trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Food Insecurity trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00501826 · 160 participants · Phase 2

    Combination Chemotherapy and Nelarabine in Treating Patients With T-cell Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma

  • NCT00932139 · 160 participants · NA

    Effect of Electro-Acupuncture on Blood Pressure

  • NCT00992901 · 160 participants · Early Phase 1

    Role of Neural and Hormonal Regulation Factors on Insulin Secretion After Gastric Bypass Surgery

  • NCT01515527 · 160 participants · Phase 2

    Cladribine Plus Low Dose Cytarabine (LDAC) Alternating With Decitabine in Patients With Acute Myeloid Leukemia (AML) or High-Risk Myelodysplastic Syndrome (MDS)

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT07090083, the US trial registry maintained by the National Library of Medicine. NCT07090083 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.